COMPARISON OF THE EFFICACY OF MYCOPHENOLATE MOFETIL AFTER ORAL OR INTRAVENOUS ADMINISTRATION IN THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE

被引:0
|
作者
Zheng, Xinhui [1 ,2 ]
Pang, AiMing [1 ,2 ]
Jiang, Erlie [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P247
引用
收藏
页码:318 / 318
页数:1
相关论文
共 50 条
  • [21] Mycophenolate mofetil as acute graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation in a murine model.
    Huang, H
    Zheng, WY
    Lin, MF
    Fu, JY
    Zhang, RH
    BLOOD, 2001, 98 (11) : 325B - 325B
  • [22] MYCOPHENOLATE MOFETIL FOR THE TREATMENT MEMBRANOUS NEPHROPATHY ASSOCIATED WITH CHRONIC GRAFT-VERSUS-HOST DISEASE
    Karambelkar, Ameet
    Bhattarai, Manoj
    Schaefer, Heidi
    Bastacky, Sheldon
    Johnson, John P.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 63 (05) : A63 - A63
  • [23] The effect of mycophenolate mofetil in steroid refractory or dependent chronic graft-versus-host disease
    Soydan, EA
    Arat, M
    Topcuoglu, P
    Ozcan, M
    Arslan, O
    Idilman, R
    Gurman, G
    Beksac, M
    Akan, H
    Ilhan, O
    BONE MARROW TRANSPLANTATION, 2003, 31 : S135 - S136
  • [24] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    B Mookerjee
    V Altomonte
    G Vogelsang
    Bone Marrow Transplantation, 1999, 24 : 517 - 520
  • [25] Treatment of acute and chronic graft versus host disease with mycophenolate mofetil.
    Ilhan, O
    Çelebi, H
    Arat, M
    Arslan, Ö
    Akçaglayan, E
    Üstün, C
    Özcan, M
    Gürman, G
    Akan, H
    Konuk, N
    Beksaç, M
    Uysal, A
    Koç, H
    BLOOD, 1999, 94 (10) : 368B - 368B
  • [26] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    Mookerjee, B
    Altomonte, V
    Vogelsang, G
    BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 517 - 520
  • [27] PREVENTION AND TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
    HERVE, P
    PRESSE MEDICALE, 1991, 20 (33): : 1614 - 1621
  • [28] PREVENTION AND TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE
    NEUDORF, S
    FILIPOVICH, A
    RAMSAY, N
    KERSEY, J
    SEMINARS IN HEMATOLOGY, 1984, 21 (02) : 91 - 100
  • [29] Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation
    Kharfan-Dabaja, Mohamed
    Mhaskar, Rahul
    Reljic, Tea
    Pidala, Joseph
    Perkins, Janelle B.
    Djulbegovic, Benjamin
    Kumar, Ambuj
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [30] Mycophenolate mofetil and cyclosporine as graft-versus-host disease prophylaxis after allogeneic blood stem cell transplantation
    Bornhäuser, M
    Schuler, U
    Pörksen, G
    Naumann, R
    Geissler, G
    Thiede, C
    Schwerdtfeger, R
    Ehninger, G
    Thiede, HM
    TRANSPLANTATION, 1999, 67 (04) : 499 - 504